Supplementary Figure S5 from TNIK Overexpression Is Sufficient for Chemoradiation Resistance in Limited-Stage Small Cell Lung Cancer
Year: 2026
Type: supplementary-materials
Abstract: Supplementary Figure S5 shows: a) Response to treatment with either cisplatin or etoposide for 48h in SCLC cell lines, determined by the CellTiter-Glo 2.0 assay. b) Synergy assessment of NCB-0846 in combination with cisplatin or etoposide in H446 and DMS114 cells using the zero-interaction potency model (ZIP).
Authors: Dipanwita Dutta Chowdhury, Eddie L. Imada, Nick Connis, Jinhee Chang, Aaron Chan, Hwai Wei Tseng, Audrey Lafargue, Francesca A. Carrieri, Triet Nguyen, Danielle N. Waters, Elan R. Simms, Amol C. Shetty, Yang Song, Muhammad Ajmal Khan, Mohammad Rezaee, Phuoc T. Tran, Luigi Marchionni, Christine L. Hann
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7204999547
Cites:
Cited by:
Related to: